Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
QMRO Home
Blizard Institute
Centre for Neuroscience, Surgery and Trauma
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
QMRO Home
Blizard Institute
Centre for Neuroscience, Surgery and Trauma
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
View/
Open
Accepted version (473.3Kb)
Accepted version (Figures) (1.937Mb)
Volume
9
Pagination
110 - 117
DOI
10.1016/j.msard.2016.07.011
Journal
MULTIPLE SCLEROSIS AND RELATED DISORDERS
ISSN
2211-0348
Metadata
Show full item record
Authors
Agahozo, MC; Peferoen, L; Baker, D; Amor, S
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15382
Collections
Centre for Neuroscience, Surgery and Trauma
[1394]
Licence information
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright statements
© 2016 Elsevier B.V. All rights reserved.